To Evaluate Effect of Food of DA-5222 in Healthy Adult Subjects

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 21, 2025

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions

Healthy

Interventions

DRUG

DA-5222

single dose administration (DA-5222 one tablet once a day)

Trial Locations (1)

Bumin Hospital, Seoul

All Listed Sponsors

lead

Dong-A ST Co., Ltd.

INDUSTRY

NCT06993168 - To Evaluate Effect of Food of DA-5222 in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter